Cartesian Therapeutics Inc. (NASDAQ: RNAC)
$19.1050
+0.0850 ( +0.87% ) 11.0K
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Market Data
Open
$19.1050
Previous close
$19.0200
Volume
11.0K
Market cap
$483.14M
Day range
$18.0700 - $19.6550
52 week range
$11.6650 - $41.8700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 47 | Aug 08, 2024 |
10-q | Quarterly Reports | 106 | Aug 08, 2024 |
pre | Proxies and info statements | 4 | Aug 02, 2024 |
4 | Insider transactions | 1 | Jul 05, 2024 |
3 | Insider transactions | 5 | Jul 03, 2024 |
4 | Insider transactions | 1 | Jul 03, 2024 |
8-k | 8K-related | 50 | Jul 02, 2024 |
8-k | 8K-related | 13 | Jun 17, 2024 |
8-k | 8K-related | 15 | May 22, 2024 |
8-k | 8K-related | 46 | May 08, 2024 |